The Benefits of
Drug-Free Migraine Management
Pharmacological treatments may fall short for many migraine patients, highlighting the need for effective and tolerable care options. The Nerivio® REN Wearable is proven to provide effective migraine relief with no pills or needles and may serve as a safe first-line prescribed intervention.
Who Can Benefit the Most from a Non-Pharmacological REN Wearable for Migraine?
Nerivio may be an optimal migraine management option for the following patient groups:
Children and Teenagers with Migraine
Younger patients often struggle with medication side effects, dislike taking pills, or fear injections.[1] The REN wearable offers a safe, non-invasive solution, empowering them to manage migraine effectively and independently in their daily lives.
Those Who Need to Reduce or Withdraw Medications:
Many individuals experience unpleasant side effects to migraine medications and some must even limit or stop using them due to health risks. Nerivio provides an alternative that eliminates these risks while delivering effective relief.
When Health Conditions Prevent Medication Use
Patients with comorbidities and underlying health conditions may find traditional migraine medications unsafe. Nerivio provides an effective option that avoids complications associated with systemic treatments.
When Occupation Limits
Medication Use
Individuals in safety-sensitive jobs, like police officers or heavy machinery operators, often cannot use medications that impair performance. Nerivio enables migraine management without compromising safety at work.
Women in Their
Reproductive Years
Hormonal changes during menstruation, breastfeeding, and menopause can complicate migraine care. Nerivio offers a safe, drug-free alternative for women seeking relief during these sensitive phases.
Veterans with Migraine-Related Challenges
Veterans often face unique health complexities, such as PTSD or risks associated with certain medications, making drug-free treatment essential. Nerivio offers safe and effective migraine relief without systemic side effects or dependence.
The Limitations of Pharmacological Migraine Treatment in Children and Teenagers
Adequate treatment during childhood may prevent chronic or refractory migraine in adulthood [2]. But, many children don’t like to swallow pills and fear injections. Others have difficulties sticking to their pharmacological treatment plans. In some cases, medication treatment may be delayed or even stopped due to unpleasant side effects, dosing issues, or rebound headaches [1].
A survey study found that the REN wearable empowers students to manage migraine attacks effectively, independently, and discreetly at school, significantly increasing in-school treatment rates and reducing barriers such as trips to the nurse’s office [3].
Rebound Headaches: A Hidden Risk of Over-Reliance on Migraine Medications
For individuals seeking relief from migraine, medication can feel like a lifeline—but excessive use of certain drugs may lead to a debilitating condition known as Rebound Headache or Medication Overuse Headache (MOH). Rebound Headache occurs when pain relief medications, particularly over-the-counter pain relievers, triptans, or opioids, are used too frequently. Instead of alleviating symptoms, these medications can actually cause more frequent and severe headaches, trapping sufferers in a cycle of dependency and pain [4].
By choosing a drug-free migraine treatment, you can break this cycle and reduce the risk of Rebound Headaches, allowing for effective migraine management without compromising your long-term health.
How can Nerivio benefit your migraine treatment?
Nerivio may reduce migraine medication intake, thus reducing medication side effects
Nerivio does not cause drowsiness, rebound headaches or systemic side effects
Nerivio offers on-the-go treatment, enhancing work performance and productivity
Nerivio allows adolescents to perform treatment in class without disruptions
Clinical Data Highlight:
Promising results suggest that Nerivio is effective as a stand-alone migraine treatment
A clinical study examining REN's impact among adolescent patients demonstrates promising results, indicating reduced medication dependency and improved migraine management outcomes (Esparham et al, 2023) [5].
Users Share Their Experiences on Reducing Medications
Sources
- Taddeo D, Egedy M, Frappier JY. Adherence to treatment in adolescents. Paediatr Child Health. 2008;13(1):19-24. doi:10.1093/pch/13.1.19https://pmc.ncbi.nlm.nih.gov/articles/PMC2528818/
- Charles, J.A., Peterlin, B.L., Rapoport, A.M. et al. Favorable outcome of early treatment of new onset child and adolescent migraine-implications for disease modification. J Headache Pain 10, 227–233 (2009). Link
- Children 2024, 11(11), 1286; https://doi.org/10.3390/children11111286Hershey AD, Shmuely S, Stark-Inbar A, Asmar Y, Ironi A, Strong E, Kabbouche M. Patterns, Barriers, and Preferences of Treating Migraine Within the School Setting: A Survey Study of Students. Children. 2024; 11(11):1286. https://doi.org/10.3390/children11111286
- Scher, A., Rizzoli, P., & Loder, E. (2017). Medication overuse headache. Neurology, 89, 1296 - 1304. https://doi.org/10.1212/WNL.0000000000004371.
- Esparham A, Stark-Inbar A, Jekel L, et al. Acute Treatment of Migraine in Adolescents: Real-World Analysis of Remote Electrical Neuromodulation (REN). Pediatr Neurol. 2023;142:51-55. doi:10.1016/j.pediatrneurol.2023.02.008